title: Delayed presentation of ACE inhibitor-induced angio-oedema.
abstract: We report two probable cases of delayed presentation of ACE inhibitor (ACEi)-induced angio-oedema. The first patient was on ACEi for more than 10 years while the second one was on it for 7 years. Both the patients presented with initial unilateral swelling of the tongue which progressed further to involve the soft tissues of the oropharynx, head and neck leading to a compromised airway needing awake fibreoptic intubation and were managed successfully in the intensive care unit (ICU). C1 esterase inhibitor and mast cell tryptase level was normal for both patients. Both were treated with intravenous antihistamines and corticosteroids in the ICU. Both patients were successfully extubated within 72 h and transferred to a medical ward. Age above 65 years, atopy and non-steroidal anti-inflammatory drug use may have been the predisposing factors. Both patients made a full recovery with no complications and the ACEi was ceased.
authors.affiliation: Department of ICU, Robina Hospital, Gold Coast, Queensland, Australia.
authors.forename: Guy
authors.initials: G
authors.lastname: Amey
authors.forename: Pasan
authors.initials: P
authors.lastname: Waidyasekara
authors.forename: Ramanathan
authors.initials: R
authors.lastname: Kollengode
mesh_terms: D000368:Aged; D000799:Angioedema / Q000139:chemically induced* / Q000175:diagnosis; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D057210:Delayed Diagnosis; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D014060:Tongue Diseases / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors
references.citation: Jpn Circ J. 1996 Mar;60(3):166-70
references.pmid: 8741242
references.citation: Am J Health Syst Pharm. 2008 Mar 1;65(5):420-1
references.pmid: 18281733
references.citation: Ann Pharmacother. 2009 Apr;43(4):772-6
references.pmid: 19299323
references.citation: Laryngoscope. 2011 Nov;121(11):2327-34
references.pmid: 22020885
references.citation: Allergy Asthma Proc. 2008 Jan-Feb;29(1):88-92
references.pmid: 18302843
references.citation: Arch Intern Med. 2005 Jul 25;165(14):1637-42
references.pmid: 16043683
references.citation: BMJ. 1992 Apr 11;304(6832):941-6
references.pmid: 1581715
references.citation: Allergol Int. 2008 Dec;57(4):441-3
references.pmid: 18946239
references.citation: BMJ Case Rep. 2012 Aug 30;2012:
references.pmid: 22936825
references.citation: Br J Clin Pharmacol. 2009 Aug;68(2):271-3
references.pmid: 19694749
references.citation: Anaesthesia. 2004 Mar;59(3):283-9
references.pmid: 14984528
references.citation: Drug Saf. 1998 Mar;18(3):171-88
references.pmid: 9530537
references.citation: J Clin Hypertens (Greenwich). 2010 Oct;12(10):765-75
references.pmid: 21029339
references.citation: Ann Allergy Asthma Immunol. 2008 Nov;101(5):495-9
references.pmid: 19055203
references.citation: Ann Emerg Med. 2010 Sep;56(3):278-82
references.pmid: 20447725